Αρχειοθήκη ιστολογίου

Παρασκευή 18 Αυγούστου 2017

How does our understanding of signaling pathways inform treatment decisions in CLL and FL?

Prof Paolo Ghia speaks at the 'Defining treatment strategies for CLL & FL in the era of targeted therapies' symposium at EHA 2017 about the mechanisms of action and associated adverse effect profiles for idelalisib, ibrutinib and venetoclax. Click here...

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2uOqcWE
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader